Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,291 | -$33,904 | -$25,521 | -$13,675 |
| Dep. & Amort. | $2,553 | $2,931 | $2,697 | $1,916 |
| Deferred Tax | $0 | -$70 | -$396 | $0 |
| Stock-Based Comp. | $2,299 | $2,432 | $1,223 | $1,656 |
| Change in WC | $2,038 | -$12,157 | -$704 | $1,028 |
| Other Non-Cash | $3,707 | $9,882 | $3,814 | $20 |
| Operating Cash Flow | -$12,694 | -$30,886 | -$18,887 | -$9,056 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,451 | -$1,858 | -$4,167 | -$3,800 |
| Net Acquisitions | $0 | $0 | $0 | $46 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,451 | -$1,858 | -$4,167 | -$3,754 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,311 | $38,812 | $28,437 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,367,253 | $38,690 | $27,764 | $18,494 |
| Financing Cash Flow | $3,367 | $38,690 | $27,764 | $18,494 |
| Forex Effect | $184 | -$240 | $85 | $62 |
| Net Chg. in Cash | -$10,594 | $5,707 | $4,795 | $5,747 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,773 | $23,066 | $18,271 | $12,525 |
| End Cash | $18,179 | $28,773 | $23,066 | $18,271 |
| Free Cash Flow | -$14,145 | -$32,743 | -$23,054 | -$12,855 |